AU Patent

AU2003214110A1 — 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces

Assigned to BASF Schweiz AG · Expires 2003-09-29 · 23y expired

What this patent protects

A method is provided for the antimicrobial treatment of a surface which comprises the contacting a surface with substituted 4-aminopyrimidines.

USPTO Abstract

A method is provided for the antimicrobial treatment of a surface which comprises the contacting a surface with substituted 4-aminopyrimidines.

Drugs covered by this patent

Velsipity (Etrasimod Arginine) · Pfizer Inc.

Patent Metadata

Patent number: AU2003214110A1
Jurisdiction: AU
Classification: —
Expires: 2003-09-29
Drug substance claim: No
Drug product claim: No
Assignee: BASF Schweiz AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.